Actis GC - Search Results

1

Cell-mediated cytotoxicity to autologous hepatocytes in HBsAg positive liver disease: an analysis of the killing specificity and of the clinical use of the test.

Actis GC, Touscoz GA, Crivelli O, Rizzetto M, Rocca B, Poli G, Verme G. Actis GC, et al. Boll Ist Sieroter Milan. 1984 Mar;63(1):19-29. Boll Ist Sieroter Milan. 1984. PMID: 6206876

2

Autologous hepatocytes in hepatitis B virus (HBV) related liver disease: a problem of liver cell culture.

Actis GC, Touscoz GA, Saracco G. Actis GC, et al. Prog Clin Biol Res. 1983;143:309-16. Prog Clin Biol Res. 1983. PMID: 6669582 No abstract available.

3

Cell-mediated immunity to acetaldehyde in alcoholic liver disease demonstrated by leukocyte migration test.

Actis GC, Ponzetto A, Rizzetto M, Verme G. Actis GC, et al. Am J Dig Dis. 1978 Oct;23(10):883-6. doi: 10.1007/BF01072460. Am J Dig Dis. 1978. PMID: 362901

4

Patterns of natural killer cell function activation in response to interferon in chronic HBsAG positive hepatitis: relationship with the state of viral infection and with the early clinical response.

Actis GC, Maran E, Bonino F, Saracco G, Rosina F, Brunetto MR, Baldi M, Rizzetto M, Verme G, Rocca B. Actis GC, et al. J Biol Regul Homeost Agents. 1987 Jan-Mar;1(1):45-50. J Biol Regul Homeost Agents. 1987. PMID: 2461050

5

Hepatitis B virus replication and clinical outcome in carriers of HBsAg. Perspectives of treatment with DNA inhibitors.

Bonino F, Recchia S, Farci P, Actis GC, Rizzetto M, Verme G, Gerin J. Bonino F, et al. Among authors: actis gc. Liver. 1983 Feb;3(1):30-5. doi: 10.1111/j.1600-0676.1983.tb00847.x. Liver. 1983. PMID: 6855488

6

Normal lymphocyte interferon production in adult HBsAg-positive chronic active liver disease.

Ponzetto A, Zucca M, Marcucci F, Rizzetto M, Actis GC, Bonino F, Gioannini P. Ponzetto A, et al. Among authors: actis gc. J Med Virol. 1979;4(1):43-50. doi: 10.1002/jmv.1890040106. J Med Virol. 1979. PMID: 528984

7

HLA-DR antigens in HBsAg-positive chronic active liver disease with and without associated delta infection.

Forzani B, Actis GC, Verme G, Amoroso A, Borelli I, Curtoni ES, Rumi MG, Picciotto A, Marinucci G, Freni MA, et al. Forzani B, et al. Among authors: actis gc. Hepatology. 1984 Nov-Dec;4(6):1107-10. doi: 10.1002/hep.1840040602. Hepatology. 1984. PMID: 6594313

8

Natural killer response to exogenous interferon in delta hepatitis: boost or depression defined within the first week of therapy.

Actis GC, Maran E, Rosina F, Saracco G, Rocca G, Rizzetto M, Bonino F, Verme G. Actis GC, et al. Digestion. 1987;37(1):51-8. doi: 10.1159/000199487. Digestion. 1987. PMID: 3609505

9

Treating chronic liver disease: lessons from a day hospital.

Lagget M, Actis GC, Brunetto MR, Verme G, Bonino F. Lagget M, et al. Among authors: actis gc. Ital J Gastroenterol. 1992 Jun;24(5):242-4. Ital J Gastroenterol. 1992. PMID: 1623222

10

Chronic active hepatitis B. Interferon-activated natural killer-like cells against a hepatoma cell line transfected with the hepatitis B virus nucleic acid.

Actis GC, Ponzetto A, D'Urso N, Saracco G, Crepaldi T, Bellone G, Catucci LM, Zarcone D, Verme G. Actis GC, et al. Liver. 1991 Apr;11(2):106-13. doi: 10.1111/j.1600-0676.1991.tb00500.x. Liver. 1991. PMID: 1646927

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters